1-6 of 6
Smriti Shrestha, MS, MA
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Alternative Donor Hematopoietic Cell Transplantation (HCT) After Reduced Intensity (RIC) or Nonmyeloablative (NST) Conditioning in Advanced Non-Hodgkin Lymphoma (NHL).

Gregory A. Hale, MD, Smriti Shrestha, MS, MA, Jennifer LeRademacher, PhD, Hillard M Lazarus, MD, Ginna G. Laport, MD, Silvia Montoto, MD, Parameswaran N Hari, MD
Journal: Blood
Blood (2009) 114 (22): 3380.
https://doi.org/10.1182/blood.V114.22.3380.3380
Published: 2009
Journal Articles

Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for Myeloma (MM) - Chronic Graft Versus Host Disease (GVHD) is Associated with Lower Risk of Relapse and Superior Progression Free Survival (PFS) - A CIBMTR Analysis.

Parameswaran N Hari, MD, A. John Barrett, MD, Smriti Shrestha, MS, MA, Gisela Tunes da Silva, PhD, Mei-Jie Zhang, PhD, Angela Dispenzieri, MD, Gustavo A. Milone, MD, Sagar Lonial, MD, Olle Ringden, MD
Journal: Blood
Blood (2009) 114 (22): 53.
https://doi.org/10.1182/blood.V114.22.53.53
Published: 2009
Journal Articles

Autologous Hematopoietic Stem Cell Transplantation (HCT) is a Safe and Effective Treatment for Primary Plasma Cell Leukemia: The CIBMTR Experience.

Anuj Mahindra, MD, David Vesole, MD, PhD, Matt E. Kalaycio, MD, Jorge Vela-Ojeda, MD, Smriti Shrestha, MS, MA, Mei-Jie Zhang, PhD, Angela Dispenzieri, MD, Gustavo A. Milone, MD, Sagar Lonial, MD, Parameswaran N. Hari, MD, MS
Journal: Blood
Blood (2009) 114 (22): 532.
https://doi.org/10.1182/blood.V114.22.532.532
Published: 2009
Journal Articles

Allogeneic Stem Cell Transplantation (SCT) for Multiple Myeloma (MM) - What Has Changed? : A CIBMTR Analysis From 1989 – 2005.

Shaji Kumar, MD, Smriti Shrestha, MS, MA, Mei-Jie Zhang, PhD, Angela Dispenzieri, MD, Gustavo A. Milone, MD, Sagar Lonial, MD, Parameswaran N. Hari, MD, MS
Journal: Blood
Blood (2009) 114 (22): 54.
https://doi.org/10.1182/blood.V114.22.54.54
Published: 2009
Journal Articles

Outcome of Patients with IgD and IgM Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplants: A Retrospective CIBMTR Study.

Donna E. Reece, MD, David H. Vesole, MD, PhD, Smriti Shrestha, MS, MA, Angela Dispenzieri, M.D., Gustavo Milone, MD, Waleska S. Peréz, MPH, Mei-Jie Zhang, PhD, Parameswaran Hari, MD, MS
Journal: Blood
Blood (2008) 112 (11): 3328.
https://doi.org/10.1182/blood.V112.11.3328.3328
Published: 2008
Journal Articles

HLA Specificities and Predisposition to the Development of Multiple Myeloma (MM).

Meral Beksac, MD, Martin Maiers, Loren Gragert, Stephen Spellman, Smriti Shrestha, MS, MA, Mei-Jie Zhang, PhD, Angela Dispenzieri, MD, Donna E. Reece, MD, David H. Vesole, MD, PhD, Parameswaran Hari, MD, MS
Journal: Blood
Blood (2008) 112 (11): 1688.
https://doi.org/10.1182/blood.V112.11.1688.1688
Published: 2008